NCT04574102View on ClinicalTrials.gov

Clinical Investigation of Omega Refractive Capsule Model V With Use of an FDA Approved IOL

NACompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

December 9, 2020

Primary Completion Date

June 9, 2021

Study Completion Date

November 15, 2021

Conditions

Cataract

Interventions

DEVICE

Omega Refractive Capsule with FDA approved Intraocular Lens

Omega Refractive Capsule with FDA approved Intraocular Lens

DEVICE

FDA approved Intraocular lens

FDA approved Intraocular lens

Trial Locations (1)

Unknown

Clinica 20/20, San José

Sponsors

Lead Sponsor

Omega Ophthalmics

All Listed Sponsors

lead

Omega Ophthalmics

INDUSTRY

NCT04574102 - Clinical Investigation of Omega Refractive Capsule Model V With Use of an FDA Approved IOL | Biotech Hunter | Biotech Hunter